NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.035 HKD | -2.78% |
|
-2.78% | -30.00% |
| Mar. 25 | New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 18 | New Ray Medicine International Forecasts Decline in 2023 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
New Ray Medicine International Holding Limited is an investment holding company principally engaged in the trading of pharmaceutical products in China. The Company operates its business through four segments. The Injection Drugs segment is engaged in the trading of injection drugs. The Capsule and Granule Drugs segment is engaged in the trading of capsule and granule drugs. The Tablet Drugs segment is engaged in the trading of tablet drugs. The Others segment is engaged in the trading of miscellaneous types of goods and drugs.
Sector
Drug Retailers
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.00% | 7.7M | |
| -33.59% | 15.3B | |
| -28.13% | 11.07B | |
| +9.74% | 6.13B | |
| -10.97% | 5.95B | |
| +0.88% | 4.79B | |
| +53.60% | 4.36B | |
| -10.49% | 3.69B | |
| -12.53% | 3.43B | |
| -6.85% | 3.05B |
- Stock Market
- Equities
- 6108 Stock
- News New Ray Medicine International Holding Limited
- New Ray Medicine International Forecasts Decline in 2023 Loss
